159 related articles for article (PubMed ID: 34565776)
1. Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.
Suzuki H; Niizeki T; Shirono T; Koteda Y; Kinjyo Y; Mizukami N; Koda M; Ota S; Nakano M; Okamura S; Iwamoto H; Shimose S; Noda Y; Kamachi N; Kajiwara A; Suda K; Akiba J; Yano H; Kuromatsu R; Koga H; Torimura T
Intern Med; 2022 Apr; 61(8):1145-1150. PubMed ID: 34565776
[TBL] [Abstract][Full Text] [Related]
2. Fontan-associated liver disease and hepatocellular carcinoma in adults.
Kogiso T; Tokushige K
Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
[TBL] [Abstract][Full Text] [Related]
3. Fontan-associated liver disease: A review.
Gordon-Walker TT; Bove K; Veldtman G
J Cardiol; 2019 Sep; 74(3):223-232. PubMed ID: 30928109
[TBL] [Abstract][Full Text] [Related]
4. Detection of hepatocellular carcinoma during Fontan-associated liver disease follow-up: a report of three cases.
Onishi H; Toh N; Akagi T; Baba K; Kotani Y; Takaki A; Kasahara S; Ito H
Clin J Gastroenterol; 2024 Feb; 17(1):148-154. PubMed ID: 38032452
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.
Sagawa T; Kogiso T; Sugiyama H; Hashimoto E; Yamamoto M; Tokushige K
Hepatol Res; 2020 Jul; 50(7):853-862. PubMed ID: 32219953
[TBL] [Abstract][Full Text] [Related]
6. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
[TBL] [Abstract][Full Text] [Related]
7. A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.
Ikeda M; Okusaka T; Sato Y; Furuse J; Mitsunaga S; Ueno H; Morizane C; Inaba Y; Kobayashi T; Arai Y
Jpn J Clin Oncol; 2017 Jun; 47(6):512-519. PubMed ID: 28334948
[TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity.
Iwamoto H; Shimose S; Shirono T; Niizeki T; Kawaguchi T
Clin Mol Hepatol; 2023 Jul; 29(3):593-604. PubMed ID: 36775834
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Fontan-associated hepatocellular carcinoma.
Kogiso T; Sagawa T; Taniai M; Shimada E; Inai K; Shinohara T; Tokushige K
PLoS One; 2022; 17(6):e0270230. PubMed ID: 35714161
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.
Kim BK; Park JY; Choi HJ; Kim DY; Ahn SH; Kim JK; Lee DY; Lee KH; Han KH
J Cancer Res Clin Oncol; 2011 Apr; 137(4):659-67. PubMed ID: 20552225
[TBL] [Abstract][Full Text] [Related]
11. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.
Sano S; Nakata S; Wada S; Kuroiwa M; Sakai H; Kusama K; Machida T; Nishio A; Ito I; Sodeyama H
World J Surg Oncol; 2019 Dec; 17(1):229. PubMed ID: 31878937
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma.
Ueshima K; Kudo M; Takita M; Nagai T; Tatsumi C; Ueda T; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Minami Y; Chung H
Oncology; 2010 Jul; 78 Suppl 1():148-53. PubMed ID: 20616598
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma after the Fontan procedure in a 16-year-old girl: A case report.
Oh C; Youn JK; Han JW; Kim GB; Kim HY; Jung SE
Medicine (Baltimore); 2016 Oct; 95(41):e4823. PubMed ID: 27741102
[TBL] [Abstract][Full Text] [Related]
14. A case of Fontan-related hepatocellular carcinoma successfully treated with proton beam therapy.
Ogasawara Y; Kogiso T; Sagawa T; Kodama K; Taniai M; Numajiri H; Sakurai H; Tokushige K
Clin J Gastroenterol; 2020 Feb; 13(1):73-78. PubMed ID: 31273674
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
[TBL] [Abstract][Full Text] [Related]
16. The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery.
Sakamori R; Yamada R; Tahata Y; Kodama T; Hikita H; Tatsumi T; Yamada T; Takehara T
J Gastroenterol; 2022 Feb; 57(2):111-119. PubMed ID: 35064829
[TBL] [Abstract][Full Text] [Related]
17. [Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report].
Tsukamoto T; Kanazawa A; Shimizu S; Murata A; Sakae M; Kurihara S; Tashima T; Deguchi S; Nakai T; Kawasaki Y; Kioka K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1878-80. PubMed ID: 26805203
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis.
Song DS; Bae SH; Song MJ; Lee SW; Kim HY; Lee YJ; Oh JS; Chun HJ; Lee HG; Choi JY; Yoon SK
World J Gastroenterol; 2013 Aug; 19(29):4679-88. PubMed ID: 23922465
[TBL] [Abstract][Full Text] [Related]
19. Challenges in Accurate Diagnosis of HCC in FALD: A Case Series.
Feeley M; Hopkins K; Grinspan LT; Schiano T; Love B; Chan A; Lewis S; Zaidi AN
Pediatr Cardiol; 2023 Oct; 44(7):1447-1453. PubMed ID: 37318608
[TBL] [Abstract][Full Text] [Related]
20. Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation.
Inuzuka R; Nii M; Inai K; Shimada E; Shinohara T; Kogiso T; Ono H; Otsuki SI; Kurita Y; Takeda A; Hirono K; Takei K; Yasukohchi S; Yoshikawa T; Furutani Y; Shinozaki T; Matsuyama Y; Senzaki H; Tokushige K; Nakanishi T
Heart; 2023 Jan; 109(4):276-282. PubMed ID: 35768191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]